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The glycolytic enzyme phosphoglucose isomerase catalyses the
reversible isomerization of glucose 6-phosphate to fructose 6-phos-
phate. The phosphoglucose isomerase from the hyperthermophilic
archaeon Pyrococcus furiosus, which shows no sequence similarity to
any known bacterial or eukaryotic phosphoglucose isomerase, has
been cloned and overexpressed in Escherichia coli, puri®ed and
subsequently crystallized by the hanging-drop method of vapour
diffusion using 1.6 M sodium citrate as the precipitant at pH 6.5.
Multiple-wavelength anomalous dispersive X-ray data have been
collected to a maximum resolution of 1.92 AÊ on a single seleno-
methionine-incorporated crystal. This crystal belongs to space group
C2, with approximate unit-cell parameters a = 84.7, b = 42.4, c = 57.3 AÊ ,
 = 120.6 and a monomer in the asymmetric unit.
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1. Introduction
Phosphoglucose isomerase (PGI; EC 5.3.1.9)
catalyses the isomerization of glucose 6-phos-
phate to fructose 6-phosphate in the Embden±
Meyerhof pathway and in the reverse direction
in gluconeogenesis (Noltmann, 1972; Rose,
1975). The Pyrococcus furiosus PGI is a dimer
of identical 21.5 kDa subunits (SWISS-PROT
accession code P83194; Verhees et al., 2001).
Sequence comparisons have revealed that
P. furiosus PGI is not related to its bacterial
and eukaryal counterparts, for which a number
of structures have been determined [e.g.
Bacillus stearothermophilus (Sun et al., 1999),
rabbit (Davies & Muirhead, 2003) and human
(Read et al., 2001)]. However, sequence simi-
larities do exist between the P. furiosus PGI
enzyme and members of the cupin superfamily
that comprises a variety of proteins generally
involved in sugar binding (Dunwell et al., 2000;
Verhees et al., 2001). This paper describes the
cloning, puri®cation, crystallization and preli-
minary X-ray analysis of P. furiosus PGI as a
®rst step in the structure determination of this
novel class of enzymes.
2. Overexpression and purification of
selenomethionine protein
Wild-type PGI was initially puri®ed from
P. furiosus cell paste and the amino-acid
sequence at the N-terminus was determined.
The corresponding pgi gene was PCR ampli-
®ed and cloned in pET24d (pLUW557),
expressed in Escherichia coli BL21 (DE3) and
puri®ed (Verhees et al., 2001). For production
of the selenomethionine-incorporated protein,
the pLUW557 construct was used to transform
competent BL21 (DE3) cells. A single colony
was cultured for 3 h at 310 K in 100 ml LB
medium containing kanamycin (50 mg mlÿ1) in
a shaking incubator. The overnight culture was
then used to inoculate two 2 l ¯asks each
containing 500 ml of LB medium (50 mg lÿ1
kanamycin) and shaken at 310 K until the
turbidity reached OD600 = 1.0. The contents of
the two ¯asks were then transferred into a
sterile centrifuge bottle and centrifuged at
4200 rev minÿ1 for 10 min at room tempera-
ture. The supernatant was subsequently
discarded and the cell pellet resuspended
in supplemented minimal media [1 g lÿ1
(NH4)2SO4, 4.5 g l
ÿ1 KH2PO4, 10.5 g l
ÿ1
K2HPO4, 40 mg l
ÿ1 of all amino acids except
methionine, 40 mg lÿ1 selenomethionine,
500 mg lÿ1 adenine, guanosine, thymine and
uracil, 2 mg lÿ1 thiamine, 5 g lÿ1 glycerol,
500 mg lÿ1 sodium citrate.2H2O and 1 mM
MgSO4.7H2O] containing 50 mg l
ÿ1 kanamycin
at 310 K. The 50 ml of concentrated cell
suspension was then used to inoculate a
small bench-top fermenter containing 3.5 l of
supplemented minimal media containing
50 mg lÿ1 kanamycin at 310 K. The turbidity of
the culture was monitored closely to ensure
growth remained in the logarithmic phase
until an OD600 of 0.8 was reached (starting
OD600 = 0.35). At this point. 2 mM IPTG was
added to the culture. The culture was then
fermented overnight at 310 K before
harvesting the cells by centrifugation at
4200 rev minÿ1 and 277 K. The supernatant
was discarded and the cell paste was frozen at
253 K for future use. Analysis of pre- and post-
induction samples using SDS±PAGE showed a
strong post-expression band at approximately
24 kDa, in good agreement with earlier results
(Verhees et al., 2001).
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Puri®cation was performed as previously
described for the wild-type recombinant
protein (Verhees et al., 2001) with the
following changes. Resuspension of over-
expressing cells was performed in 40 mM
Tris±HCl pH 8.0, 2 mM EDTA (buffer A)
and disrupted by ultrasonication for 3 10 s
at 10 mm amplitude. The resulting cell-free
extract was incubated at 338 K for 25 min
and centrifuged at 70 000g for 20 min at
277 K. The lower temperature incubation
step compared with that reported previously
exposed the protein to less harsh conditions
but nevertheless effectively removed the
majority of the contaminating E. coli
proteins. The soluble fraction was loaded
onto a 20 ml Q-Sepharose Fast Flow column
(Amersham Biosciences) equilibrated in
buffer A and was eluted using a linear
gradient of NaCl from 0 to 1 M in buffer A.
The protein concentration of the fractions
was measured using the method of Bradford
(1976) with BioRad dye reagent (Bio-Rad
Laboratories GmbH, Germany) and the
purity was analysed by SDS±PAGE
(NuPAGE 4±12% bis-tris gel; Novex). The
purest fractions were combined and loaded
onto a 16/60 HiLoad Superdex 200 column
(Amerham Biosciences) equilibrated in
buffer B (50 mM Tris±HCl pH 8.0, 0.5 M
NaCl). PGI was eluted from the column with
buffer B. Peak fractions were combined and
concentrated on a Vivaspin concentrator to
give a ®nal concentration of 14 mg mlÿ1.
This equates to a yield of 18 mg of PGI per
litre of cell culture.
3. Crystallization and preliminary X-ray
analysis
The level of overexpression of seleno-
methionine-incorporated PGI was estimated
to be approximately 15% of the total soluble
cell protein. The purity of PGI, as deter-
mined by SDS±PAGE (4±12% bis-tris
NuPAGE gel, Novex), was approximately
90%, with a yield of 21 mg of protein
measured using the Bradford assay (Brad-
ford, 1976). The level of selenomethionine
incorporation in the PGI protein was
determined by positive ionization nano-
electrospray mass spectrometry using the
Q-Tof (Micromass UK, Ltd) mass spectro-
meter at the Mass Spectrometry Facility at
the University of Leeds and was shown to be
greater than 95%.
A preliminary crystallization screen was
carried out by the hanging-drop method of
vapour diffusion (290 K) using Hampton
Research Crystal Screen kits and a protein
concentration of approximately 14 mg mlÿ1.
Crystals of the methionine and seleno-
methionine protein grew optimally in 1.6 M
sodium citrate dihydrate pH 6.5 (condition
No. 28) after 2±3 weeks. These crystals had
maximal dimensions of 0.5  0.5  0.2 mm
and a plate-like morphology.
For data collection, a single seleno-
methionine-incorporated crystal was ¯ash-
frozen straight out of the drop at 100 K.
Subsequently, multiple-wavelength anom-
alous diffraction (MAD) data were collected
from this crystal to a maximum resolution
of 1.92 AÊ using a MAR Research CCD
detector on beamline BM14 at the ESRF,
Grenoble, France. Three wavelengths were
chosen near the selenium-absorption edge
based on a ¯uorescence absorption spec-
trum obtained from the frozen crystal
in order to maximize the f 00 component
(1, peak), to minimize the f
0 component
(2, in¯ection) and to maximize f
0 (3,
remote). To ensure all Bijvoet pairs were
measured, a total of 120 images of 1.5
rotation per image were collected at each
wavelength. The crystal had a mosaicity that
varied between 0.5 and 0.9 depending on its
orientation. The data for each wavelength
were processed individually and scaled in
such a way as to preserve the anomalous
signal using the DENZO/SCALEPACK
package (Otwinowski & Minor, 1997).
Details of the data-collection statistics are
presented in Table 1.
Preliminary analysis of the X-ray diffrac-
tion data using the autoindexing routine in
DENZO indicated that the crystal belonged
to space group C2, with unit-cell parameters
a = 84.7, b = 42.4, c = 57.3 AÊ ,  = 120.6
and a corresponding unit-cell volume of
1.8  105 AÊ 3. Consideration of the values of
VM suggests that the asymmetric unit
contains a monomer with a VM value of
2.1 AÊ 3 Daÿ1, which is within the range
observed by Matthews for protein crystals
(Matthews, 1977). A full structural deter-
mination is currently under way in order to
provide insights into the key determinants of
the function of this class of PGIs, for which
no structures are currently available.
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Table 1
X-ray data-collection statistics for the selenomethionine-incorporated PGI crystal collected on beamline BM14
at ESRF, Grenoble, France.
Values in parentheses refer to the highest resolution shell.
Data set Peak (1) In¯ection (2) Remote (3)
Wavelength (AÊ ) 0.97897 0.979389 0.89843
Resolution (AÊ ) 50±2.09 (2.16±2.09) 50±2.09 (2.16±2.09) 50±1.92 (1.99±1.92)
Re¯ections measured 87131 85980 116064
Re¯ections rejected 437 474 299
Unique re¯ections 10188 (648) 10167 (666) 13134 (900)
Multiplicity 3.7 (3.2) 3.7 (3.0) 3.7 (3.1)
Completeness (%) 96.5 (66.0) 96.3 (64.2) 96.5 (66.7)
hI/(I)i 38.9 (10.3) 37.7 (9.3) 32.5 (6.35)
hI/(I)i, I > 3² (%) 91.6 (85.0) 90.5 (84.5) 85.4 (72.6)
Rmerge³ 0.064 (0.140) 0.055 (0.121) 0.057 (0.162)
² The percentage of re¯ections with I/(I) greater than three. ³ Rmerge =
P jI ÿ hIij=P I, where I is the integrated intensity of a
given re¯ection.
